The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Underlying host immune dysregulation in cancer patients developing immune-related adverse events.
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Samsung Bioepis
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - ArQule (Inst); BerGenBio (Inst); ImClone Systems (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Bristol-Myers Squibb; Lilly; Lilly
 
Shaheen Khan
No Relationships to Disclose
 
Xin Luo
No Relationships to Disclose
 
Saad A. Khan
Honoraria - ARIAD; EMD Serono; Genentech/Roche; Genzyme
Consulting or Advisory Role - ARIAD; EMD Serono; Foundation Medicine; Genentech/Roche; Guardant Health; Oak Ridge Associated Universities; Takeda
Speakers' Bureau - Genzyme
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Celldex (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Novartis
 
Farjana Fattah
No Relationships to Disclose
 
Jessica Saltarski
No Relationships to Disclose
 
Yvonne Gloria-McCutchen
No Relationships to Disclose
 
Jason Park
Employment - Miraca Holdings
Stock and Other Ownership Interests - Targeted Cancer Therapeutics
Honoraria - Miraca Holdings
Consulting or Advisory Role - Miraca Holdings
Patents, Royalties, Other Intellectual Property - Targeted Cancer Therapeutics; Thomas Jefferson University
 
Yang Xie
No Relationships to Disclose
 
Quan Li
No Relationships to Disclose
 
Edward Wakeland
No Relationships to Disclose